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Objective
To investigate the phenotypic relationships between aor-
tic stiffness and left ventricular (LV) modes of deforma-
tion in patients with rheumatoid arthritis (RA) with
anti-TNF therapy.
Background
Excess of cardiovascular (CV) morbidity and mortality
in RA patients is not fully explained by traditional CV
risk factors. Evidence suggests the presence of inflam-
mation-induced vascular and myocardial injury and dys-
function, leading to premature atherosclerosis and heart
failure. Aortic stiffness, an independent predictor of car-
diac events and a marker of pulsatile LV afterload,
improves with anti-tumor necrosis factor-alpha (anti-
TNF) therapy in these patients; however, the effects on
determinants of systolic function remain undetermined.
Methods
Of the total of 24 patients with RA, free of cardiac
symptoms, thirteen subjects, eligible for anti-TNF ther-
apy as per its licensed indications, completed paired
standardized MRI assessments of aortic pulse wave velo-
city (PWV), global LV function and deformation (peak
systolic strains and rotation Figure 1), before initiation
and after 3-month of therapy. To avoid confounding
with a possible ischaemic scar, late gadolinium enhance-
ment was also performed.
Results
At the follow up, the treated group with mean age
42.221.1 years and female predominance (n=8), showed
reduced disease activity score and CRP (mean difference
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(0.75±0.32 m/s, p<0.01). Despite reduced LV end-diasto-
lic volume (EDV: 9.78.7ml, p<0.01) and increased stroke
volume (SV: 5.13.8ml, p=0.02), ejection fraction was no
different from the baseline (EF: 0.085.1%, p=0.3). LV
rotation rate significantly increased, more pronounced
in the apex than the base (rotation rate AP: -4.63.7/sec
vs. rotation rate BA: -2.12.5/sec), corresponding with a
greater improvement in apical radial strain (AP: -3.22.3
vs. BA: -2.23.2) and total longitudinal strain (long:
4.54.9) (Figure 2). In multiple regression analyses (step-
wise), baseline aortic PWV correlated independently
with log-transformed CRP and radial apical strain
(R2=0.973, p<0.001), whereas, after 3 months of therapy,
aortic PWV correlated with radial and circumferential
apical and total longitudinal strain (R2 = 0.93, p<0.001).
Measures of global systolic function showed no associa-
tions with aortic stiffness.
Conclusion
Targeted anti-inflammatory therapy, such as with anti-
TNF, is associated with improvement in aortic stiffness and
myocardial deformation in RA patients with high-grade
systemic inflammation. Our findings suggest that CV
dysfunction in these patients is inflammation-induced
and reversible. Our results may indicate a discernible CV
phenotype by means of CMR, which can be accounted for
by CV inflammation, and potentially instrumental as a
guide for new anti-inflammatory interventions.
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